India recorded 961 prosecutions for spurious and adulterated drugs in 2024–25, the highest in five years even as detection of fake medicines fell to a five-year low. Government data shows that testing expanded to more than one lakh samples annually, yet proportion of spurious drugs has declined and baseline level of Not of Standard Quality medicines has remained largely unchanged.